AstraZeneca PLC
AZN· NYSE
AZNAstraZeneca PLC
Source filing unavailable
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $14.46B | $12.94B | $11.42B | $10.77B |
| Net Income | $2.45B | $1.93B | $1.82B | $360.00M |
| EPS Diluted | $1.57 | $1.24 | $1.17 | $0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
AstraZeneca PLC · CIK 901832 · Engraved from SEC EDGAR
